Calendar Kinnate Biopharma Inc.

Equities

KNTE

US49705R1059

Market Closed - Nasdaq 04:00:00 2024-04-02 pm EDT 5-day change 1st Jan Change
2.65 USD -0.38% Intraday chart for Kinnate Biopharma Inc. -.--% +11.81%

Chart calendar Kinnate Biopharma Inc.

513cde90ac126d171baf8444f.GBwt-1uoPgMnmn1VMnCJv6yk9qvEC7t21-PcD4g5GK8.X3p9zTabXUVMqgQQZgr9083yxtybRMEV5ZGQe_lyKMJuVWWJGe4MOnLrNA~60d60de1eaa00b3bec03e6eea7a9316c

Upcoming events on Kinnate Biopharma Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-08-06 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)

Past events on Kinnate Biopharma Inc.

2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-08-08 04:05 pm Q2 2023 Earnings Release
2023-06-15 12:20 pm Goldman Sachs Global Healthcare Conference
2023-06-09 12:00 pm Annual General Meeting
2023-06-07 02:30 pm Jefferies Global Healthcare Conference
2023-05-11 04:06 pm Q1 2023 Earnings Release
2023-04-18 01:30 pm American Association for Cancer Research Meeting - Abstract No: 4927
2023-04-17 05:30 pm American Association for Cancer Research Meeting
2023-04-17 03:35 pm American Association for Cancer Research Meeting - Abstract No: 9851
2023-04-13 American Association for Cancer Research Meeting - Booth #1725
2023-03-15 04:05 pm Q4 2022 Earnings Release
2023-02-17 03:30 pm American Society of Clinical Oncology Genitourinary Cancers Symposium - Abstract No:TPS593
2023-02-14 01:40 pm SVB Securities Global Biopharma Conference
2023-01-20 03:00 pm American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract No: TPS637
2022-11-10 04:05 pm Q3 2022 Earnings Release
2022-09-22 12:30 pm Piper Sandler Heartland Summit
2022-09-09 09:10 am Wells Fargo Healthcare Conference
2022-08-11 04:05 pm Interim 2022 Earnings Release
2022-08-10 10:20 am Wedbush PacGrow Healthcare Conference
2022-06-15 01:00 pm Goldman Sachs Global Healthcare Conference - Fireside Chat

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread
0,00


-35,9
-36,0
0.23%
-90,0
-88,1
-2.17%
-118
-117
-0.5%
-120
-118
-1.96%
EBIT
Million USD
Released
Forecast
Spread
0,00


-36,0
-37,2
3.34%
-90,1
-89,6
-0.6%
-119
-117
-1.26%
-121
-121
0.16%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-35,8
-37,4
4.33%
-89,8
-89,3
-0.48%
-116
-116
-0.34%
-113
-115
2.25%
Net income
Million USD
Released
Forecast
Spread
-9,94


-35,8
-37,4
4.33%
-89,8
-89,3
-0.47%
-116
-116
0.17%
-113
-115
2.25%
EPS
USD
Released
Forecast
Spread
-2,72


-5,28
-1,48
-257.97%
-2,06
-2,05
-0.39%
-2,64
-2,64
0.13%
-2,42
-2,47
1.83%
Announcement Date04/09/2029/03/2128/03/2215/03/2328/03/24

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-26,3
-25,7
-2.16%
-27,1
-27,0
-0.37%
-27,4
-28,1
2.64%
-31,4
-28,8
-8.98%
-32,7
-31,0
-5.47%
-34,7
-33,1
-4.73%
-34,1
-34,7
1.74%
-31,1
-32,5
4.28%
-19,3
-21,3
9.22%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-26,2
-25,7
-1.66%
-26,9
-27,1
0.55%
-27,1
-28,3
4.27%
-30,7
-28,5
-7.78%
-31,6
-30,7
-2.88%
-32,9
-33,1
0.4%
-31,9
-35,0
8.87%
-30,7
-32,7
5.96%
-10,8
-20,9
48.45%
Net income
Million USD
Released
Forecast
Spread
-26,2
-25,7
-1.66%
-26,9
-27,3
1.43%
-27,1
-28,4
4.81%
-30,7
-28,7
-7.09%
-31,6
-31,2
-1%
-32,9
-33,5
1.65%
-31,9
-35,2
9.3%
-30,7
-32,6
5.76%
-10,8
-20,9
48.45%
EPS
USD
Released
Forecast
Spread
-0,60
-0,59
-1.69%
-0,61
-0,62
1.35%
-0,62
-0,65
4.41%
-0,70
-0,60
-16.11%
-0,72
-0,71
-1.41%
-0,73
-0,74
1.35%
-0,68
-0,76
10.86%
-0,65
-0,69
6.19%
-0,36
-0,44
17.87%
Announcement Date28/03/2212/05/2211/08/2210/11/2215/03/2311/05/2308/08/2309/11/2328/03/24
  1. Stock Market
  2. Equities
  3. KNTE Stock
  4. Calendar Kinnate Biopharma Inc.